Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

Matthew J Maurer (Lecturer), Lasse H. Jakobsen (Other), Norbert Schmitz (Other), Umar Farooq (Other), Christopher R. Flowers Flowers (Other), Peter de Nully Brown (Other), Frederiksen, H. (Guest lecturer), Viola Poeschel (Other), Grzegorz S. Nowakowski (Other), John Francis Seymour (Other), Francesco Francesco Merl Francesco Merli (Other), Corinne Haioun (Other), Herve Ghesquieres (Other), Marita Ziepert (Other), Hervé Tilly (Other), Gilles Andre Salles (Other), Qiang Shi (Other), Tarec Christoffer El-Galaly (Other), Carrie A Thompson (Other), Thomas M. Habermann (Other), David Cunningham (Guest lecturer), Judit M Jørgensen (Other)

Activity: Talks and presentationsConference presentations

Period8. Dec 2019
Event typeConference
LocationOrlando, United States